Skip to search formSkip to main contentSkip to account menu

pradefovir mesylate

Known as: hepavir-B, Remofovir Mesylate, 9-(2-(4-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl)methoxyethyl)adenine 
The mesylate salt form of pradefovir, a cyclodiester antiviral prodrug with specific activity against hepatitis B virus (HBV). Pradefovir is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Among patients with cirrhosis, recovery of liver function after SVR to all‐oral direct‐acting antivirals (DAA) in HIV/HCV… 
Review
2019
Review
2019
Varicella‐zoster virus and hepatitis B virus reactivations have been reported after starting interferon‐free direct‐acting… 
2016
2016
A rapid and sensitive liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of… 
2005
2005
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2004
2004
Adefovir dipivoxil (Hepsera™), a first-line therapy for chronic hepatitis B, is an esterase-activated prodrug of PMEA. Dose…